| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.636 | 5.258 | 8.383 | 6.670 | 6.200 | 7.103 | 8.834 | 16.349 |
| Total Income - EUR | - | - | 1.636 | 5.258 | 8.383 | 6.670 | 6.200 | 7.116 | 8.902 | 16.425 |
| Total Expenses - EUR | - | - | 215 | 2.750 | 21.484 | 1.353 | 282 | 2.354 | 19.818 | 4.943 |
| Gross Profit/Loss - EUR | - | - | 1.422 | 2.508 | -13.101 | 5.317 | 5.918 | 4.762 | -10.916 | 11.482 |
| Net Profit/Loss - EUR | - | - | 1.373 | 2.350 | -13.231 | 5.255 | 5.828 | 4.580 | -10.916 | 9.594 |
| Employees | - | - | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Data Qvid Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 29 | 0 | 13 | 0 | 0 | 0 | 622 | 244 |
| Current Assets | - | - | 1.437 | 3.790 | 11.447 | 1.129 | 2.930 | 7.761 | 3.654 | 17.185 |
| Inventories | - | - | 0 | 32 | 24 | 190 | 216 | 13 | 116 | 224 |
| Receivables | - | - | 0 | 0 | 9.024 | 522 | 364 | 4.047 | 1.123 | 11.489 |
| Cash | - | - | 1.437 | 3.758 | 2.399 | 416 | 2.351 | 3.701 | 2.415 | 5.472 |
| Shareholders Funds | - | - | 1.417 | 3.741 | -11.353 | -5.882 | 76 | 4.657 | -9.303 | 343 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 49 | 49 | 22.813 | 7.011 | 2.855 | 3.104 | 13.578 | 17.169 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6220 - 6220" | |||||||||
| CAEN Financial Year |
6203
|
|||||||||
Comments - Data Qvid Med Srl